http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015107946-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
filingDate | 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_989697f4c5faa5d066e8671ae4915c8b |
publicationDate | 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015107946-A |
titleOfInvention | Composition for external use |
abstract | PROBLEM TO BE SOLVED: To provide a composition for external use containing pyrroloquinoline quinone or a pharmaceutically acceptable salt thereof, which is excellent in skin permeability of pyrroloquinoline quinone or a pharmaceutically acceptable salt thereof. SOLUTION: (a) pyrroloquinoline quinone or a pharmaceutically acceptable salt thereof, and (b) consisting of 2 to 4 amino acid residues, having neutral amino acids at both ends, either one or both ends A composition for external use comprising a peptide whose terminal neutral amino acid is any one of alanine, leucine, glycine, and phenylalanine. [Selection] Figure 1 |
priorityDate | 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.